Radim Becvar
Overview
Explore the profile of Radim Becvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mongin D, Matucci-Cerinic M, Walker U, Distler O, Becvar R, Siegert E, et al.
Arthritis Care Res (Hoboken)
. 2024 Nov;
PMID: 39542851
Objective: The objective of this study is to evaluate whether adding oral glucocorticoids to immunosuppressive therapy improves skin scores and ensures safety in patients with early diffuse cutaneous systemic sclerosis...
2.
Hermankova B, Oreska S, Spiritovic M, Storkanova H, Komarc M, Pavelka K, et al.
Aging Male
. 2024 Apr;
27(1):2336630.
PMID: 38584363
Objectives: This cross-sectional study aimed to compare the sexual function (SF) and pelvic floor function of men with systemic sclerosis (SSc) with age-matched healthy controls (HC) and to identify the...
3.
Khanna D, Kramer F, Hofler J, Ghadessi M, Sandner P, Allanore Y, et al.
Rheumatology (Oxford)
. 2024 Mar;
63(11):3124-3134.
PMID: 38460548
Objective: To examine disease and target engagement biomarkers in the RISE-SSc trial of riociguat in early diffuse cutaneous systemic sclerosis and their potential to predict the response to treatment. Methods:...
4.
Distler O, Allanore Y, Denton C, Kuwana M, Matucci-Cerinic M, Pope J, et al.
Lancet Rheumatol
. 2024 Jan;
5(11):e660-e669.
PMID: 38251533
Background: The phase 2b Riociguat Safety and Efficacy in Patients with Diffuse Cutaneous Systemic Sclerosis (RISE-SSc) trial investigated riociguat versus placebo in early diffuse cutaneous systemic sclerosis. The long-term extension...
5.
Storkanova H, Storkanova L, Navratilova A, Becvar V, Hulejova H, Oreska S, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893244
In the original publication [...].
6.
Deibel E, Carreira P, Vonk M, Papa N, Becvar R, Guillen-Del-Castillo A, et al.
Arthritis Care Res (Hoboken)
. 2023 Sep;
76(1):88-97.
PMID: 37667424
Objective: The outcome of patients with COVID-19 improved over the pandemic, including patients with systemic rheumatic diseases. However, data on patients with systemic sclerosis (SSc) are lacking. This study aimed...
7.
Svec X, Storkanova H, Trinh-Minh T, Tran M, Storkanova L, Hulejova H, et al.
Rheumatology (Oxford)
. 2023 Jun;
63(3):817-825.
PMID: 37314987
Objectives: Our previous studies have demonstrated that the Damage Associated Molecular Pattern (DAMP) protein, S100A4, is overexpressed in the involved skin and peripheral blood of patients with SSc. It is...
8.
Hermankova B, Spiritovic M, Oreska S, Storkanova H, Mann H, Pavelka K, et al.
Rheumatol Ther
. 2023 May;
10(4):1089-1105.
PMID: 37221419
Introduction: Systemic sclerosis (SSc) and idiopathic inflammatory myopathies (IIM) are very rare rheumatic diseases burdened by a high prevalence of sexual dysfunctions. However, no specific treatment has been proposed to...
9.
Spiritovic M, Smucrova H, Hermankova B, Oreska S, Storkanova H, Rathouska A, et al.
Clin Exp Rheumatol
. 2022 Feb;
40(10):1941-1950.
PMID: 35200131
Objectives: The structural and functional changes of the hands and face in systemic sclerosis (SSc) can be severely disabling. We aimed to assess the effect of a 24-week supervised physiotherapy...
10.
Hermankova B, Spiritovic M, Smucrova H, Oreska S, Storkanova H, Komarc M, et al.
Int J Environ Res Public Health
. 2022 Jan;
19(1).
PMID: 35010872
Only a few studies have addressed sexual health in patients with systemic sclerosis (SSc). This study aimed to compare female sexual function and pelvic floor muscle function in SSc patients...